161 related articles for article (PubMed ID: 15175332)
21. Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer.
Gulino A; Vacca A; Modesti A; Screpanti I; Farina A; Frati L
Biochem Pharmacol; 1986 Nov; 35(21):3863-70. PubMed ID: 3778510
[TBL] [Abstract][Full Text] [Related]
22. Role of estrogen receptors and antiestrogen binding sites in an early effect of antiestrogens, the inhibition of cholesterol biosynthesis.
Cypriani B; Tabacik C; Descomps B; Crastes de Paulet A
J Steroid Biochem; 1988 Nov; 31(5):763-71. PubMed ID: 3199816
[TBL] [Abstract][Full Text] [Related]
23. Estrogen and antiestrogen binding sites in desmoid tumors.
Lim CL; Walker MJ; Mehta RR; Das Gupta TK
Eur J Cancer Clin Oncol; 1986 May; 22(5):583-7. PubMed ID: 3770030
[TBL] [Abstract][Full Text] [Related]
24. The pure antiestrogen ICI 182,780 binds to a high-affinity site distinct from the estrogen receptor.
Parisot JP; Hu XF; Sutherland RL; Wakeling A; Zalcberg JR; DeLuise M
Int J Cancer; 1995 Aug; 62(4):480-4. PubMed ID: 7635575
[TBL] [Abstract][Full Text] [Related]
25. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
Sheen YY; Simpson DM; Katzenellenbogen BS
Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol epoxide hydrolase and cancer.
Silvente-Poirot S; Poirot M
Curr Opin Pharmacol; 2012 Dec; 12(6):696-703. PubMed ID: 22917620
[TBL] [Abstract][Full Text] [Related]
27. Characterization of estrogen and antiestrogen binding to the cytosol and microsomes of breast tumors.
Lopes MC; Tavares MC; Vale MG; Carvalho AP
J Steroid Biochem Mol Biol; 1991 Sep; 39(3):343-52. PubMed ID: 1911424
[TBL] [Abstract][Full Text] [Related]
28. Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways.
Dalenc F; Giamarchi C; Petit M; Poirot M; Favre G; Faye JC
Breast Cancer Res; 2005; 7(6):R1159-67. PubMed ID: 16457696
[TBL] [Abstract][Full Text] [Related]
29. Comparative affinity of steroidal and non-steroidal antioestrogens, cholesterol derivatives and compounds with a dialkylamino side chain for the rat liver antioestrogen binding site.
van den Koedijk CD; Vis van Heemst C; Elsendoorn GM; Thijssen JH; Blankenstein MA
Biochem Pharmacol; 1992 Jun; 43(12):2511-8. PubMed ID: 1632810
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of a novel side chain modified Delta8(14)-15-ketosterol, a potential cholesterol lowering drug: 28-hydroxylation by CYP27A1.
Pettersson H; Norlin M; Andersson U; Pikuleva I; Björkhem I; Misharin AY; Wikvall K
Biochim Biophys Acta; 2008 Aug; 1781(8):383-90. PubMed ID: 18603016
[TBL] [Abstract][Full Text] [Related]
31. Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity.
Delarue F; Kedjouar B; Mésange F; Bayard F; Faye JC; Poirot M
Biochem Pharmacol; 1999 Mar; 57(6):657-61. PubMed ID: 10037451
[TBL] [Abstract][Full Text] [Related]
32. Microsomal enzymes of cholesterol biosynthesis from lanosterol. Solubilization and purification of steroid 8-isomerase.
Paik YK; Billheimer JT; Magolda RL; Gaylor JL
J Biol Chem; 1986 May; 261(14):6470-7. PubMed ID: 2422166
[TBL] [Abstract][Full Text] [Related]
33. Sterol dependent regulation of human TM7SF2 gene expression: role of the encoded 3beta-hydroxysterol Delta14-reductase in human cholesterol biosynthesis.
Bennati AM; Castelli M; Della Fazia MA; Beccari T; Caruso D; Servillo G; Roberti R
Biochim Biophys Acta; 2006 Jul; 1761(7):677-85. PubMed ID: 16784888
[TBL] [Abstract][Full Text] [Related]
34. Species specificity of triphenylethylene derivatives and of compounds with a steroidal backbone for human and rat liver antioestrogen binding site (AEBS).
van den Koedijk CD; Govers RM; Thijssen JH; Blankenstein MA
Biochem Pharmacol; 1993 Nov; 46(10):1870-2. PubMed ID: 8250976
[TBL] [Abstract][Full Text] [Related]
35. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
Gingras S; Moriggl R; Groner B; Simard J
Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
[TBL] [Abstract][Full Text] [Related]
36. Cholesterol biosynthesis from lanosterol: differential inhibition of sterol delta 8-isomerase and other lanosterol-converting enzymes by tamoxifen.
Cho SY; Kim JH; Paik YK
Mol Cells; 1998 Apr; 8(2):233-9. PubMed ID: 9638657
[TBL] [Abstract][Full Text] [Related]
37. Disruption of the gene encoding 3beta-hydroxysterol Delta-reductase (Tm7sf2) in mice does not impair cholesterol biosynthesis.
Bennati AM; Schiavoni G; Franken S; Piobbico D; Della Fazia MA; Caruso D; De Fabiani E; Benedetti L; Cusella De Angelis MG; Gieselmann V; Servillo G; Beccari T; Roberti R
FEBS J; 2008 Oct; 275(20):5034-47. PubMed ID: 18785926
[TBL] [Abstract][Full Text] [Related]
38. Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.
Burke PJ; Kalet BT; Koch TH
J Med Chem; 2004 Dec; 47(26):6509-18. PubMed ID: 15588086
[TBL] [Abstract][Full Text] [Related]
39. Binding sites of droloxifene in the cytosol of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells.
Kawamura I; Lacey E; Tanaka Y; Nishigaki F; Manda T; Shimomura K
Jpn J Cancer Res; 1994 Jun; 85(6):639-44. PubMed ID: 8063618
[TBL] [Abstract][Full Text] [Related]
40. Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.
Katzenellenbogen BS; Miller MA; Mullick A; Sheen YY
Breast Cancer Res Treat; 1985; 5(3):231-43. PubMed ID: 4027393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
